Eiger BioPharmaceuticals Inc (NASDAQ:EIGR)

8.75
Delayed Data
As of Nov 25
 -0.29 / -3.21%
Today’s Change
4.55
Today|||52-Week Range
15.82
-41.28%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Eiger BioPharmaceuticals Inc have a median target of 25.50, with a high estimate of 49.00 and a low estimate of 22.00. The median estimate represents a +191.43% increase from the last price of 8.75.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Eiger BioPharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.19
Sales
$50.0K
Reporting Date
Mar 18

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 141.25%
 
 
 
 
 
 
Growthannually 52.76%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.